Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yoko Agemi"'
Autor:
Masaharu Aga, So Okubo, Toshiki Ikeda, Yuko Higashi, Yusuke Hamakawa, Suguru Matsuzaka, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Yukiko Nakamura, Tsuneo Shimokawa, Yoshinobu Aisa, Hiroaki Okamoto
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background Cold agglutination syndrome is a subtype of autoimmune hemolytic anemia. The condition is referred to as “cold” because the antibodies become active and induce hemolysis at cold temperatures, typically 3–4 °C, which is not
Externí odkaz:
https://doaj.org/article/4b65d0747d9642b9888d06685c279c68
Autor:
Hiromune Sawada, Yuri Taniguchi, Shin Iizuka, Toshiki Ikeda, Masaharu Aga, Yusuke Hamakawa, Kazuhito Miyazaki, Yuki Misumi, Yoko Agemi, Yukiko Nakamura, Koki Maeda, Tsuneo Shimokawa, Hiroaki Okamoto
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1558-1567 (2023)
Introduction: C-ros oncogene 1 (ROS1) translocation is an oncogenic driver-mutation identified in 1–2% of non-small-cell lung cancer (NSCLC) cases. Although crizotinib, a tyrosine kinase inhibitor (TKI) against ALK/ROS1, is known to be effective ag
Externí odkaz:
https://doaj.org/article/97ef3a05d08549e587029f538dbb0f84
Autor:
Yusuke Hamakawa, Yoko Agemi, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yukiko Nakamura, Tsuneo Shimokawa, Yusuke Saigusa, Nobuaki Kobayashi, Hiroaki Okamoto, Takeshi Kaneko
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17788-17797 (2023)
Abstract Background The relationship between epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) resistance, including osimertinib, and programmed cell death‐ligand 1 (PD‐L1) expression status in EGFR‐mutated non‐small cel
Externí odkaz:
https://doaj.org/article/188fb850272d45928519dacc820d07fe
Autor:
Kazuhito Miyazaki, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Yusuke Hamakawa, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Yukiko Nakamura, Tsuneo Shimokawa, Hiroaki Okamoto
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Granulocyte colony-stimulating factor (G-CSF)-producing lung cancer induces severe inflammation and a high white blood cell (WBC) count and is associated with poor prognosis. A recent case of G-CSF-producing lung adenocarcinoma sh
Externí odkaz:
https://doaj.org/article/8e0d2321d6c1458e974c2e975ab5f691
Autor:
Kazuhito Miyazaki, Yukihiro Yoshimura, Nobuyuki Miyata, Hiroaki Sasaki, Aya Shiba, Masaharu Aga, Yusuke Hamakawa, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Tsuneo Shimokawa, Hiroaki Okamoto, Natsuo Tachikawa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Remdesivir has been shown to reduce recovery time and mortality among patients with coronavirus disease 2019 (COVID-19). However, data regarding the efficacy and safety of remdesivir use are limited in Japan. We conducted a single-center ret
Externí odkaz:
https://doaj.org/article/a6b9f983aba54cdbbfeb7d2dd7448b50
Autor:
Naoto Fukasawa, Yoko Agemi, Aya Shiba, Masaharu Aga, Yusuke Hamakawa, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Tsuneo Shimokawa, Kyoko Ono, Hiroyuki Hayashi, Hiroaki Okamoto
Publikováno v:
Respirology Case Reports, Vol 10, Iss 9, Pp n/a-n/a (2022)
Abstract Malignant pericardial mesothelioma (MPM) is a rare tumour that arises from the mesothelial cells of the pericardium. No standard treatment has been established owing to a poor treatment response; therefore, MPM has a poor prognosis. We herei
Externí odkaz:
https://doaj.org/article/27435dd171c34fa6be9b53be7db928ff
Autor:
Kazuhito Miyazaki, Yuya Hirasawa, Masaharu Aga, Naoto Aiko, Yusuke Hamakawa, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Tsuneo Shimokawa, Hiroyuki Hayashi, Katsuhiko Naoki, Hiroaki Okamoto
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is useful for diagnosing hilar and mediastinal lymph node enlargement; however, specimens obtained are often small and inadequate for pathologic diagnosis. In June
Externí odkaz:
https://doaj.org/article/2164bd340453438f9330e3c630dafb3a
Autor:
Yuri Shiraiwa, Yuri Taniguchi, Mari Hyoudou, Aya Shiba, Masaharu Aga, Kazuhito Miyazaki, Yusuke Hamakawa, Yuki Misumi, Yoko Agemi, Tsuneo Shimokawa, Chie Hasegawa, Hiroyuki Hayashi, Hiroaki Okamoto
Publikováno v:
Respiratory Medicine Case Reports, Vol 37, Iss , Pp 101631- (2022)
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare manifestation of malignancy. The antemortem diagnosis is difficult, since patients present with rapidly progressive symptoms. We recently observed a case of PTTM following lymphedema of the
Externí odkaz:
https://doaj.org/article/62baeba8325d4f8e8384462320fb3543
Autor:
Masaharu Aga, Aya Shiba, Yusuke Hamakawa, Suguru Matsuzaka, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Tsuneo Shimokawa, Hiroaki Okamoto
Publikováno v:
Respirology Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
Abstract We report an acute clinical course of pneumonia caused by Legionella pneumophila in a patient receiving chemotherapy for lung cancer and corticosteroid therapy. A 57‐year‐old man presented with fever and dyspnoea and was admitted to our
Externí odkaz:
https://doaj.org/article/1e135ed5910641188d0d6293a6407e7a
Autor:
Naoto Aiko, Tsuneo Shimokawa, Kazuhito Miyazaki, Yuki Misumi, Yoko Agemi, Mari Ishii, Yukiko Nakamura, Takeharu Yamanaka, Hiroaki Okamoto
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Compared with standard chemotherapy, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are more effective in patients with advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations. However, data c
Externí odkaz:
https://doaj.org/article/eaf475cff42747299ec4aa0a7f9904cb